Polymorphism of VEGF gene in susceptibility to chronic immune-mediated inflammatory diseases: a meta-analysis

Rheumatology International

Volumn 35, Issue 8, 2015, Pages 1351-1360

  Wei, Ni ^a   Chen, Zijia ^a   Xue, Zhifeng ^b   Zhu, Yuelan ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b PuHuangYu Community Health Service Center   (China)

Author keywords

+405G>C; Immune mediated inflammatory diseases; Meta analysis; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

5' UNTRANSLATED REGION; ALLELE; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; CHRONIC IMMUNE MEDIATED INFLAMMATORY DISEASE; DNA POLYMORPHISM; ETHNIC GROUP; ETHNICITY; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOIMMUNE DISEASE; BEHCET DISEASE; GENETIC PREDISPOSITION; GENETICS; GIANT CELL ARTERITIS; GRAVES DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; ODDS RATIO; PSORIASIS; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ALLELES; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOIMMUNE DISEASES; BEHCET SYNDROME; DIABETES MELLITUS, TYPE 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GIANT CELL ARTERITIS; GRAVES DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MUCOCUTANEOUS LYMPH NODE SYNDROME; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; SCLERODERMA, SYSTEMIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84931564637     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-015-3279-0     Document Type: Article

References (54)

1. Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, Wojnarowska F, Stevens SR, Chen M, Fairley JA, Woodley DT, Miller SD, Gordon KB (1998) Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 110:103–109. doi:10.1046/j.1523-1747.1998.00107.x
2. Molina V, Shoenfeld Y (2005) Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38:235–245. doi:10.1080/08916930500050277
3. Batycka-Baran A, Maj J, Wolf R, Szepietowski JC (2014) The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis. J Immunol Res 2014:628289. doi:10.1155/2014/628289
4. Kochi Y, Suzuki A, Yamamoto K (2014) Genetic basis of rheumatoid arthritis: a current review. Biochem Biophys Res Commun. doi:10.1016/j.bbrc.2014.07.085
5. Carmona FD, Gonzalez-Gay MA, Martin J (2014) Genetic component of giant cell arteritis. Rheumatology (Oxford) 53:6–18. doi:10.1093/rheumatology/ket231
6. Ness T, Bley TA, Schmidt WA, Lamprecht P (2013) The diagnosis and treatment of giant cell arteritis. Dtsch Arztebl Int 110:376–385. doi:10.3238/arztebl.2013.0376(quiz 386)
7. Yeom JS, Woo HO, Park JS, Park ES, Seo JH, Youn HS (2013) Kawasaki disease in infants. Korean J Pediatr 56:377–382. doi:10.3345/kjp.2013.56.9.377
8. Sadick H, Naim R, Gossler U, Hormann K, Riedel F (2005) Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density. Int J Mol Med 15:15–19
9. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676. doi:10.1038/nm0603-669
10. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437:169–183. doi:10.1042/BJ20110301
11. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039
12. Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2:795–803. doi:10.1038/nrc909
13. Wang Z, Liang W, Zhang B, Lv M, Wang J, Zhang L (2008) Single nucleotide polymorphisms of VEGF gene and Psoriasis risk. J Dermatol Sci 49:263–265. doi:10.1016/j.jdermsci.2007.10.003
14. Vural P, Baki M, Dogru-Abbasoglu S, Ozderya A, Karadag B, Uysal M (2012) Vascular endothelial growth factor polymorphisms increase the risk of developing Graves’ disease. Int Immunopharmacol 14:133–137. doi:10.1016/j.intimp.2012.06.018
15. Del Bo R, Ghezzi S, Scarpini E, Bresolin N, Comi GP (2009) VEGF genetic variability is associated with increased risk of developing Alzheimer’s disease. J Neurol Sci 283:66–68. doi:10.1016/j.jns.2009.02.318
16. Gong JY, Sun YH (2013) Association of VEGF gene polymorphisms with diabetic retinopathy: a meta-analysis. PLoS ONE 8:e84069. doi:10.1371/journal.pone.0084069
17. Mandal RK, Yadav SS, Panda AK, Khattri S (2013) Vascular endothelial growth factor 936 c>T polymorphism increased oral cancer risk: evidence from a meta-analysis. Genet Test Mol Biomark 17:543–547. doi:10.1089/gtmb.2013.0020
18. Yan Y, Liang H, Li T, Guo S, Li M, Li S, Qin X (2014) Vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 13 case–control studies. Tumour Biol 35:2687–2692. doi:10.1007/s13277-013-1354-2
19. Chen GQ, Luo JB, Wang GZ, Ding JE (2014) Assessment of the associations between three VEGF polymorphisms and risk of prostate cancer. Tumour Biol 35:1875–1879. doi:10.1007/s13277-013-1250-9
20. da Costa BR, Cevallos M, Altman DG, Rutjes AW, Egger M (2011) Uses and misuses of the STROBE statement: bibliographic study. BMJ Open 1:e000048. doi:10.1136/bmjopen-2010-000048
21. Jackson D, White IR, Riley RD (2012) Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 31:3805–3820. doi:10.1002/sim.5453
22. Young HS, Summers AM, Bhushan M, Brenchley PE, Griffiths CE (2004) Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 122:209–215. doi:10.1046/j.0022-202X.2003.22107.x
23. Barile S, Medda E, Nistico L, Bordignon V, Cordiali-Fei P, Carducci M, Rainaldi A, Marinelli R, Bonifati C (2006) Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis. Exp Dermatol 15:368–376. doi:10.1111/j.0906-6705.2006.00416.x
24. Wongpiyabovorn J, Yooyongsatit S, Ruchusatsawat K, Avihingsanon Y, Hirankarn N (2008) Association of the CTG (−2578/−460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis. Tissue Antigens 72:458–463. doi:10.1111/j.1399-0039.2008.01134.x
25. Wu J, Ren X, Zhang X, Li C, Li Y, Ma H, Zhou Y, Jin Y, Chen F, Bai J, Fu S (2010) The vascular endothelial growth factor +405 G/C polymorphism in psoriasis. J Dermatol Sci 57:62–63. doi:10.1016/j.jdermsci.2009.10.009
26. Zablotna M, Sobjanek M, Nedoszytko B, Lange M, Kozicka D, Glen J, Roszkiewicz J (2013) Association of psoriasis with the VEGF gene polymorphism in the northern Polish population. J Eur Acad Dermatol Venereol 27:319–323. doi:10.1111/j.1468-3083.2011.04393.x
27. Han SW, Kim GW, Seo JS, Kim SJ, Sa KH, Park JY, Lee J, Kim SY, Goronzy JJ, Weyand CM, Kang YM (2004) VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology (Oxford) 43:1173–1177. doi:10.1093/rheumatology/keh281
28. Rueda B, Gonzalez-Gay MA, Lopez-Nevot MA, Garcia A, Fernandez-Arquero M, Balsa A, Pablos JL, Pascual-Salcedo D, de la Concha EG, Gonzalez-Escribano MF, Martin J (2005) Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis. Hum Immunol 66:864–868. doi:10.1016/j.humimm.2005.05.004
29. Lv HZ, Lin T, Xia LP, Shen H, Zhu XY, Zhang JT, Xiao WG, Lu J (2011) Vascular endothelial growth factor gene polymorphisms and rheumatoid arthritis. J Investig Med 59:593–598. doi:10.231/JIM.0b013e31820c9e21
30. Zhang Y, Qiu H, Zhang H, Wang L, Zhuang C, Liu R (2013) Vascular endothelial growth factor A (VEGFA) polymorphisms in Chinese patients with rheumatoid arthritis. Scand J Rheumatol 42:344–348. doi:10.3109/03009742.2013.787454
31. Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, Mizuno Y, Hara T (2004) Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 56:953–959. doi:10.1203/01.pdr.0000145280.26284.b9
32. Breunis WB, Biezeveld MH, Geissler J, Ottenkamp J, Kuipers IM, Lam J, Hutchinson A, Welch R, Chanock SJ, Kuijpers TW (2006) Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum 54:1588–1594. doi:10.1002/art.21811
33. Hsueh KC, Lin YJ, Chang JS, Wan L, Tsai YH, Tsai CH, Chen CP, Tsai FJ (2008) Association of vascular endothelial growth factor C-634 g polymorphism in taiwanese children with Kawasaki disease. Pediatr Cardiol 29:292–296. doi:10.1007/s00246-007-9049-3
34. Huang FY, Chang TY, Chen MR, Lee HC, Chi H, Chiu NC, Hsu CH, Lin SP, Kao HA, Chen WF, Chan HW, Liu HF, Chu CC, Lin M, Lee YJ (2008) Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children. J Clin Immunol 28:322–328. doi:10.1007/s10875-008-9185-4
35. Boiardi L, Casali B, Nicoli D, Farnetti E, Chen Q, Macchioni P, Catanoso MG, Pulsatelli L, Meliconi R, Salvarani C (2003) Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol 30:2160–2164
36. Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martin J, Gonzalez-Gay MA (2005) A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol 32:1737–1741
37. Enjuanes A, Benavente Y, Hernandez-Rodriguez J, Queralt C, Yague J, Jares P, de Sanjose S, Campo E, Cid MC (2012) Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA–a simultaneous study of 130 potentially functional SNPs in 14 candidate genes. Rheumatology (Oxford) 51:841–851. doi:10.1093/rheumatology/ker429
38. McKnight AJ, Maxwell AP, Patterson CC, Brady HR, Savage DA (2007) Association of VEGF-1499C→T polymorphism with diabetic nephropathy in type 1 diabetes mellitus. J Diabetes Complicat 21:242–245. doi:10.1016/j.jdiacomp.2006.05.005
39. Kangas-Kontio T, Vavuli S, Kakko SJ, Penna J, Savolainen ER, Savolainen MJ, Liinamaa MJ (2009) Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. Br J Ophthalmol 93:1401–1406. doi:10.1136/bjo.2009.159012
40. Salvarani C, Boiardi L, Casali B, Olivieri I, Cantini F, Salvi F, Malatesta R, La Corte R, Triolo G, Ferrante A, Filippini D, Paolazzi G, Sarzi-Puttini P, Nicoli D, Farnetti E, Chen Q, Pulsatelli L (2004) Vascular endothelial growth factor gene polymorphisms in Behcet’s disease. J Rheumatol 31:1785–1789
41. Nam EJ, Han SW, Kim SU, Cho JH, Sa KH, Lee WK, Park JY, Kang YM (2005) Association of vascular endothelial growth factor gene polymorphisms with Behcet disease in a Korean population. Hum Immunol 66:1068–1073. doi:10.1016/j.humimm.2005.08.238
42. Lv HZ, Lin T, Zhu XY, Zhang JT, Lu J (2010) A study on relationship between single nucleotide polymorphisms of vascular endothelial growth factor gene and susceptibility to systemic lupus erythematosus in China north Han population. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26:1189–1192
43. Wongpiyabovorn J, Hirankarn N, Ruchusatsawat K, Yooyongsatit S, Benjachat T, Avihingsanon Y (2011) The association of single nucleotide polymorphism within vascular endothelial growth factor gene with systemic lupus erythematosus and lupus nephritis. Int J Immunogenet 38:63–67. doi:10.1111/j.1744-313X.2010.00960.x
44. Allanore Y, Borderie D, Airo P, Guiducci S, Czirjak L, Nasonov EL, Riemekasten G, Caramaschi P, Majdan M, Krasowska D, Friedl E, Lemarechal H, Ananieva LP, Nievskaya T, Ekindjian OG, Matucci-Cerinic M, Kahan A (2007) Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients. Ann Rheum Dis 66:257–259. doi:10.1136/ard.2006.054346
45. Butt C, Lim S, Greenwood C, Rahman P (2007) VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. BMC Musculoskelet Disord 8:1. doi:10.1186/1471-2474-8-1
46. Ferrante M, Pierik M, Henckaerts L, Joossens M, Claes K, Van Schuerbeek N, Vlietinck R, Rutgeerts P, Van Assche G, Vermeire S (2006) The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease. Inflamm Bowel Dis 12:870–878. doi:10.1097/01.mib.0000235095.01608.10
47. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581–611. doi:10.1210/er.2003-0027
48. Vanaja MC, Rozati R, Nassaruddin K, Vishnupriya S (2013) Association of VEGF +405G>C polymorphism with endometriosis. Front Biosci (Elite Ed) 5:748–754
49. Moradzadegan A, Vaisi-Raygani A, Nikzamir A, Rahimi Z (2014) Angiotensin converting enzyme insertion/deletion (I/D) (rs4646994) and Vegf polymorphism (+405G/C; rs2010963) in type II diabetic patients: association with the risk of coronary artery disease. J Renin Angiotensin Aldosterone Syst. doi:10.1177/1470320313497819
50. Gentilini D, Somigliana E, Vigano P, Vignali M, Busacca M, Di Blasio AM (2008) The vascular endothelial growth factor +405G>C polymorphism in endometriosis. Hum Reprod 23:211–215. doi:10.1093/humrep/dem341
51. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506–511. doi:10.1038/nature01621
52. Barratt BJ, Payne F, Lowe CE, Hermann R, Healy BC, Harold D, Concannon P, Gharani N, McCarthy MI, Olavesen MG, McCormack R, Guja C, Ionescu-Tirgoviste C, Undlien DE, Ronningen KS, Gillespie KM, Tuomilehto-Wolf E, Tuomilehto J, Bennett ST, Clayton DG, Cordell HJ, Todd JA (2004) Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 53:1884–1889
53. Botting KJ, McMillen IC, Forbes H, Nyengaard JR, Morrison JL (2014) Chronic hypoxemia in late gestation decreases cardiomyocyte number but does not change expression of hypoxia-responsive genes. J Am Heart Assoc. doi:10.1161/JAHA.113.000531
54. Sweet RL, Zastre JA (2013) HIF1-alpha-mediated gene expression induced by vitamin B1 deficiency. Int J Vitam Nutr Res 83:188–197. doi:10.1024/0300-9831/a000159